We are very please to announce a marketing alliance with the Japanese company JVCKENWOOD Corporation in order to distribute all BIOMIMESYS® products in Japan and some parts of Asia. We are honored to work with a such famous brand.

JVCKENWOOD will begin developing sales of HCS Pharma products through collaboration with AS ONE Corporation, which has a diverse sales network in the research, industrial, and medical fields with advanced products, information, and logistics.

Through the alliance with HCS Pharma, JVCKENWOOD aims to deploy biotechnology products in drug discovery-related fields as well as developing business related to the presymptomatic state and early diagnosis support by integrating with biodevices for specimen testing and the exosome measurement system ExoCounter in the biotechnology market.

The complete press release is available below.

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.